Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus

IntroductionLipid control is essential in type 2 diabetes mellitus (T2DM). The aim of this study is to investigate factors associated with lipid therapy adherence and achievement of goals in real-life setting among patients with recently diagnosed T2DM.Research design and methodsThis is a longitudin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ open diabetes research & care 2021-02, Vol.9 (1), p.e001891
Hauptverfasser:	García-Ulloa, Ana Cristina, Lechuga-Fonseca, Claudia, Del Razo-Olvera, Fabiola Mabel, Aguilar-Salinas, Carlos Alberto, Galaviz, Karla Ivette, Narayan, K M Venkat, Hernández-Jiménez, Sergio
Format:	Artikel
Sprache:	eng
Schlagworte:	Cholesterol Chronic illnesses Diabetes Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Drug dosages Endocrinology Epidemiology/Health services research Female Goals Health surveys Humans Hypothyroidism Lipids Low density lipoprotein Male Medical diagnosis Metabolism Middle Aged Normal distribution Patient compliance Pharmaceutical Preparations Prescription drugs Prescriptions Statins Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	IntroductionLipid control is essential in type 2 diabetes mellitus (T2DM). The aim of this study is to investigate factors associated with lipid therapy adherence and achievement of goals in real-life setting among patients with recently diagnosed T2DM.Research design and methodsThis is a longitudinal analysis in a center of comprehensive care for patients with diabetes. We include patients with T2DM,
ISSN:	2052-4897 2052-4897
DOI:	10.1136/bmjdrc-2020-001891